PHAR Statistics

Total Valuation

Egyptian International Pharmaceutical Industries Company has a market cap or net worth of EGP 7.33 billion. The enterprise value is 14.42 billion.

Market Cap	7.33B
Enterprise Value	14.42B

Important Dates

The next estimated earnings date is Sunday, November 10, 2024.

Earnings Date	Nov 10, 2024
Ex-Dividend Date	Apr 28, 2024

Share Statistics

Egyptian International Pharmaceutical Industries Company has 148.76 million shares outstanding.

Shares Outstanding	148.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	0.16%
Float	56.10M

Valuation Ratios

The trailing PE ratio is 6.71.

PE Ratio	6.71
Forward PE	n/a
PS Ratio	1.16
PB Ratio	1.60
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.88, with an EV/FCF ratio of -3.96.

EV / Earnings	13.19
EV / Sales	2.27
EV / EBITDA	8.88
EV / EBIT	9.47
EV / FCF	-3.96

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 1.80.

Current Ratio	1.65
Quick Ratio	0.72
Debt / Equity	1.80
Debt / EBITDA	5.34
Debt / FCF	-2.27
Interest Coverage	2.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.61% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+41.61%
50-Day Moving Average	42.96
200-Day Moving Average	41.50
Relative Strength Index (RSI)	67.58
Average Volume (20 Days)	697,645

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Egyptian International Pharmaceutical Industries Company had revenue of EGP 6.34 billion and earned 1.09 billion in profits. Earnings per share was 7.34.

Revenue	6.34B
Gross Profit	2.77B
Operating Income	1.45B
Pretax Income	1.43B
Net Income	1.09B
EBITDA	1.55B
EBIT	1.45B
Earnings Per Share (EPS)	7.34

Full Income Statement

Balance Sheet

The company has 1.18 billion in cash and 8.26 billion in debt, giving a net cash position of -7.08 billion or -47.60 per share.

Cash & Cash Equivalents	1.18B
Total Debt	8.26B
Net Cash	-7.08B
Net Cash Per Share	-47.60
Equity (Book Value)	4.60B
Book Value Per Share	30.88
Working Capital	3.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.07 billion and capital expenditures -2.57 billion, giving a free cash flow of -3.64 billion.

Operating Cash Flow	-1.07B
Capital Expenditures	-2.57B
Free Cash Flow	-3.64B
FCF Per Share	-24.47

Full Cash Flow Statement

Margins

Gross margin is 43.70%, with operating and profit margins of 22.82% and 17.22%.

Gross Margin	43.70%
Operating Margin	22.82%
Pretax Margin	22.54%
Profit Margin	17.22%
EBITDA Margin	24.37%
EBIT Margin	22.82%
FCF Margin	-57.38%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.03%.

Dividend Per Share	1.00
Dividend Yield	2.03%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	34.80%
Buyback Yield	n/a
Shareholder Yield	2.03%
Earnings Yield	14.90%
FCF Yield	-49.65%

Dividend Details

Stock Splits

The last stock split was on February 28, 2019. It was a forward split with a ratio of 1.25.

Last Split Date	Feb 28, 2019
Split Type	Forward
Split Ratio	1.25

Scores

Egyptian International Pharmaceutical Industries Company has an Altman Z-Score of 1.54. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.54
Piotroski F-Score	n/a